Seaport Therapeutics, Inc. Common Stock enterprise value

The Enterprise Value as of November 2026 (TTM) for Seaport Therapeutics, Inc. Common Stock (SPTX) is 663.25M

According to Seaport Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 663.25M. This represents a change of -28.53% compared to the average of 927.96M of the last 4 quarters.

Seaport Therapeutics, Inc. Common Stock (SPTX) Historical Enterprise Value (quarterly & annually)

How has SPTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Seaport Therapeutics, Inc. Common Stock over the last ten years is 725.78M. The current 663.25M Enterprise Value has changed -8.62% with respect to the historical average. Over the past ten years (40 quarters), SPTX's Enterprise Value was at its highest in in the June 2026 quarter at 1.10B. The Enterprise Value was at its lowest in in the September 2026 quarter at 675.91M.

Seaport Therapeutics, Inc. Common Stock (SPTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Seaport Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seaport Therapeutics, Inc. Common Stock (SPTX) Average Enterprise Value

How has SPTX Enterprise Value performed in the past?

The current Enterprise Value of Seaport Therapeutics, Inc. Common Stock (SPTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seaport Therapeutics, Inc. Common Stock (SPTX) Enterprise Value vs. Peers

How is SPTX’s Enterprise Value compared to its peers?

Seaport Therapeutics, Inc. Common Stock’s Enterprise Value is less than LB Pharmaceuticals Inc Common Stock (1.00B), less than Rapport Therapeutics, Inc. Common Stock (1.16B), greater than Neumora Therapeutics, Inc. Common Stock (-35792711.00), greater than MapLight Therapeutics, Inc. (249.07M), less than GH Research PLC (1.07B), greater than Vanda Pharmaceuticals Inc. (187.10M), greater than Quantum BioPharma Ltd. (12.33M), greater than Pasithea Therapeutics Corp. (-33290412.00), greater than Contineum Therapeutics, Inc. (302.33M), greater than Serina Therapeutics, Inc. (9.73M),

Build a custom stock screener for Seaport Therapeutics, Inc. Common Stock (SPTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seaport Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seaport Therapeutics, Inc. Common Stock (SPTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seaport Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.